Taiwan's government will formalize plans by the end of July to allocate NT$1 billion (US$33.9 million) to hold clinical trials of COVID-19 vaccine candidates with the goal of developing an effective vaccine by the first quarter of 2021, according to the head of the Food and Drug Administration (FDA).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Honduras exploring Taiwan, S. Korea markets for hard-hit white shrimp
04/02/2025 09:49 PM - Society
Taiwan reports 1st fatal Coxsackie B5 enterovirus case in a decade
04/02/2025 09:16 PM - Business
Taiwan's foreign arrivals estimated to rise 3% in Q1
04/02/2025 08:30 PM - Society
Autopsy scheduled for newborn baby found abandoned in Chiayi
04/02/2025 08:20 PM - Society
Taiwanese woman dies in Myanmar quake while on way to make donations
04/02/2025 07:27 PM